Home / Industry / Pharmaceuticals & Biotechnology / Antimalarial Drugs Market

Antimalarial Drugs Market

Antimalarial Drugs Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: Mar 2026 | Format: | No. of Pages: 198

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Customisation / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Antimalarial Drugs Market

The global market for antimalarial drugs has surpassed the US$1.2 billion mark in 2026 and will possibly reach around US$2 billion by the end of 2033. The report projects a promising CAGR of more than 5% for the market during 2026 - 2033.

The primary factors projected to drive the global antimalarial drugs market expansion is due to growing expenditure in the healthcare industry, and rising prevalence of malaria.

Hospital pharmacies remain the leading distribution channel, whereas the aminoquinolines represent the most sought-after drug class.

Pfizer Inc., Novartis AG, Roche Holding AG, Merck & Co, Sanofi SA, GlaxoSmithKline Plc, Sun Pharmaceutical Industries Ltd., AbbVie Inc, Bayer AG, and Cipla Limited are some of the biggest names in this industry.

Currently, Asia Pacific spearheads the global industry, and the trend will most likely prevail through the end of 2033.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services